๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Immunosuppressive therapy for myelodysplastic syndromes: Refining the indications

โœ Scribed by A. John Barrett; Elaine M. Sloand

Publisher
Current Science Inc.
Year
2008
Tongue
English
Weight
140 KB
Volume
3
Category
Article
ISSN
1558-8211

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Immunosuppressive therapy for hypoplasti
Immunosuppressive therapy for hypoplastic myelodysplastic syndrome
โœ Douwe H. Biesma; Jan G. van den Tweel; Leo F. Verdonck ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 199 KB ๐Ÿ‘ 1 views

## Background: Hypoplastic myelodysplastic syndrome (mds) is characterized by dysplasia and hypocellularity. the treatment of choice for young patients is bone marrow transplantation. ## Methods: This report describes the effect of immunosuppressive therapy in two patients with hypoplastic mds fo

Successful immunosuppressive therapy for
Successful immunosuppressive therapy for a child with Myelodysplastic syndrome
โœ Orimoto, Mizue ;Maeda, Miho ;Cai, Ling-zhi ;Hayakawa, Jun ;Ueda, Takahiro ;Migit ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 66 KB

chemotherapeutic regimen is unknown but commonly prescribed drugs include vincristine, doxorubicin and cyclophosphamide [1,[3][4][5]10]. Simple observation of small, accessible, solitary lesions in clinically well infants has been recommended in the absence of adverse prognostic features. These incl

Novel therapies for myelodysplastic synd
Novel therapies for myelodysplastic syndromes
โœ Stefan Faderl; Hagop M. Kantarjian ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 209 KB

## Abstract ## BACKGROUND The assessment of patients with myelodysplastic syndromes (MDS) and the choice of therapies remain challenging. New therapies are now emerging after the identification of molecular targets that result in improvement of hematologic parameters and may hold promise for the p